Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.


NDAQ:TLRY - Post by User

Post by Savage97on May 26, 2023 2:45am
277 Views
Post# 35465219

King Cannabis Irwin Simon Ahead of his Game

King Cannabis Irwin Simon Ahead of his GameThis offering is not one of common stock, which triggers actual dilution of the stock shareholders own and/or trade. Other than interest payments, Tilray will not be obligated to pay back this money until 6-15-27 (four years) and the stock being issued to the institutional investors will not be convertible to common stock prior to that date unless the price moves above 130% from the price at the time of the offering, which I believe was $2.39 -/+ Therefore - no real concern here unless we do not see close to $5 before the conversion obligation date of 6-15-27.
<< Previous
Bullboard Posts
Next >>